The following list of cancer immunotherapies are available for licensing under U.S. Patent Publication No.: 20220235325.
Stimulation of Dendritic Cell Activity by Homotaurine and Analogues Thereof
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |
| Upfront Fee | Annual Minimum Royalty | Phase 1 IND | Phase 2 IND | Phase 3 IND | BLA | Royalty |
|---|---|---|---|---|---|---|
| $50,000 | $10,000 | $100,000 | $250,000 | $500,000 | $1,000,000 | 6% |